Lipid profile reference intervals in individuals from Maracaibo, Venezuela: an insight from the Maracaibo City Metabolic Syndrome prevalence study

Fuente: Redalyc

Guardado en:

Detalles Bibliográficos
Autor principal:	Valmore J. Bermúdez
Formato:	Artículo científico
Lenguaje:	en
Publicado:	Sociedad Latinoamericana de Hipertensión 2012
Materias:	Medicina Dyslipidemia Lipid Profile Reference Intervals Cardiovascular Disease
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Evaluating the differential benefits of varying carbohydrate-restricted diets on lipid profiles and cardiovascular risks in dyslipidemia: a meta-analysis and systematic review.
por: Liu, Kang, et al.
Publicado: (2025)

Lipid Profile Patterns in Women with Uterine Fibroids: A Case Control Study in Northwestern Nigeria
por: Sanni, M, et al.
Publicado: (2026)

Lipid Profile Patterns in Women with Uterine Fibroids: A Case Control Study in Northwestern Nigeria
por: Musa, S, et al.
Publicado: (2026)

Dyslipidemia as a long-term marker for survival in pulmonary embolism
por: L. Jara-Palomares
Publicado: (2011)

Approach on the Use of Statins in a Sample of Doctors from Argentina. The COFEMA Study
por: Andrés Rosende
Publicado: (2016)

ERICA: prevalence of dyslipidemia in Brazilian adolescents
por: José Rocha Faria-Neto
Publicado: (2016)

Coconut oil increases HDL-c and decreases triglycerides in wistar rats
por: Lidiani Figueiredo Santana
Publicado: (2016)

Coronary artery events one year after revascularization: a single center experience
por: Marwan Kamil Aboud
Publicado: (2021)

Lipid-lowering drug prescriptions in a group of Colombian patients
por: Andrés Gaviria-Mendoza
Publicado: (2019)

Influence of pharmacotherapy complexity on compliance with the therapeutic objectives for HIV+ patients on antiretroviral treatment concomitant with therapy for dyslipidemia. INCOFAR Project
por: Rocío Jiménez Galán
Publicado: (2016)

Molecular mechanisms of Endothelial Dysfunction: from the nitric oxide synthesis to ADMA inhibition
por: Valmore Bermúdez
Publicado: (2007)

Effect of Versus Simvastatin on the Skeletal Muscles of Experimentally Induced Dyslipidemia: A Multitarget Approach to Muscle Ultrastructural and Cytomolecular Modulation.
por: Abdelhady, Mai E, et al.
Publicado: (2025)

Effects of high intensity intermittent training on lipid profile and blood glucose overweight/obese university students
por: Diana Paola Montealegre Suárez
Publicado: (2022)

Total cholesterol in dyslipidemias. Is it a useful measure?
por: Lauren Sofía Calvo-Betancourt
Publicado: (2019)

One year follow-up of the cardio-metabolic profile evolution in renal transplant patients treated with alemtuzumab, cyclosporine, and steroids in a reference hospital in Colombia
por: John Fredy Nieto-Ríos
Publicado: (2015)

LIFESTYLE STATUS, FOOD CONSUMPTION PATTERN AND IT S RELATION TO DYSLIPIDEMIA
por: Mehrzad Moghadasi
Publicado: (2010)

Mathematical Foundations of Myocardial Re-Tensioning: Resolving PIEZO2 Reflexes via the 1.29 MHz Metric Sync
por: Pivetta, Adrian Neill
Publicado: (2026)

Transcriptomic Signature of Lipid Production in Australian Aurantiochytrium sp. TC20.
por: Lee Chang, Kim Jye, et al.
Publicado: (2025)

Associations of metabolic phenotypes with cardiac structure, and clinical outcomes: insights from the UK Biobank
por: Bogner, Balazs, et al.
Publicado: (2025)

Protective Effects of Neutral Lipids from on Palmitate-Induced Lipid Accumulation in HepG2 Cells: An In Vitro Model of Non-Alcoholic Fatty Liver Disease.
por: Peyras, Marion, et al.
Publicado: (2026)

Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer
por: Nila Ganamurali, et al.
Publicado: (2025)

Cardiovascular disease risk markers in children under 10 years of age and their relationship with serum concentrations of IGF-1, IGFBP-1, IGFBP-2 and IGFBP-3
por: Sorany Vera
Publicado: (2020)

Clinical Outcomes Of The CDC Panchakarma Protocol With Prameha Diet Box In Type 2 Diabetes Mellitus With Metabolic And Cardiovascular Comorbidities: A Real-World Observational Study
por: Priyadarshini Bhalekar1*, Vidya Patil2, Dipali Sarjerao2
Publicado: (2026)

A Novel Hypothesis for the Protective Rise in Cholesterol Sulfate Against Lipid Metabolic Disorders
por: Xiaoyue Li, et al.
Publicado: (2025)

O USO DA PSICOTERAPIA PARA PREVENÇÃO DE DOENÇAS CARDIOVASCULARES
por: Pereira, Allana, et al.
Publicado: (2024)

Data base Peripheral neuropathic and renal complications in patients with diabetes mellitus 2
por: EVELYN, GOICOCHEA RIOS, et al.
Publicado: (2025)

Data base Peripheral neuropathic and renal complications in patients with diabetes mellitus 2
por: EVELYN, GOICOCHEA RIOS, et al.
Publicado: (2025)

Lipid Metabolism in Pregnancy Women with Hypothyroidism and Potential Influence on Pregnancy Outcome
por: Yuxin Qin, et al.
Publicado: (2024)

Lipid and lipoprotein particle profiles in patients with type 2 diabetes mellitus: A comparative study between highlanders and lowlanders
por: Chenghui Zhang, et al.
Publicado: (2025)

Network Pharmacology Insights Into Statin‐Induced Coenzyme Q10 Deficiency: Lipid Metabolic Crosstalk, TNF – MAPK Signaling, and Muscle Toxicity
por: Nila Ganamurali, et al.
Publicado: (2025)

A Comparative Study of Cardiovascular Disease Risk Factors among Rural and Urban Population of Karbi Anglong, Assam
por: International Journal of Medical Science and Advanced Clinical Research (IJMACR)
Publicado: (2025)

Analysis of Interhospital Transfer of Critically Ill Patients to the Coronary Care Unit of a Highly Complex Hospital
por: Maximiliano De abreu
Publicado: (2017)

Value of the monocyte‐to‐high‐density lipoprotein cholesterol ratio in refining the detection of prevalent heart failure: Insights from the NHANES 1999–2018
por: Letian Wang, et al.
Publicado: (2024)

Is the Treatment of Coronary Artery Disease Following the Recommendations Set Out in the Proposed Guidelines and in the SYNTAX Study?
por: Helmgton José Brito de Souza
Publicado: (2025)

ACSL1 Contributes to Metabolic‐Associated Fatty Liver Disease by Mediating Arachidonic Acid Metabolism
por: Meiao Tan, et al.
Publicado: (2025)

Prevalencia del síndrome metabólico en la población adulta Añú de la laguna de Sinamaica del municipio Páez, estado Zulia
por: Valmore J. Bermúdez P.
Publicado: (2009)

TMAO, A Gut Microbiome Derived Metabolite, and its Contribution to the Development of Cardiovascular Disease (CVD)
por: Bin Ishaq, Mussab, et al.
Publicado: (2026)

Melatonin Promotes Improvement in Serum Lipid Levels and Liver Histopathology in Hyperlipidemic Rats
por: Ana Cláudia Carvalho de Sousa, et al.
Publicado: (2026)

Covid-19 in Brazil in 2020: impact on deaths from cancer and cardiovascular disease
por: Jardim, Beatriz, et al.
Publicado: (2021)

Lipid‐Soluble Signaling Molecular Model Predicts Prognosis and Immunotherapy Response in Gastric Cancer
por: Wenwen Zhu, et al.
Publicado: (2026)